17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

43 Suppliers, 28 USDMF, 11 CEP/COS, 4 JDMF, 5 EU WC, 19 NDC API, 15 Listed Suppliers

DEVELOPMENTS

18 Drug(s) in Development

18 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

4 Suppliers

4 Suppliers

DOSSIERs // Finished Dosage Forms

288 Dossiers, 136 FDA Orange Book, 71 Europe, 30 Canada, 8 Australia, 27 South Africa, 16 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL-28 - 0.03MG;0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.02MG,0.15MG;0.025MG,0.15MG;0.03MG,0.15MG;0.01MG,N/A, INTRAUTERINE DEVICE;INTRAUTERINE - 52MG, TABLET;ORAL - 0.02MG;0.1MG, INTRAUTERINE DEVICE;INTRAUTERINE - 52MG, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.045MG/24HR;0.015MG/24HR, TABLET;ORAL - 1.5MG

RELATED EXCIPIENT COMPANIES

Suppliers, 29 Kerry, 17 Roquette, 17 BASF, 11 Sigachi Industries, 11 Corel Pharma Chem, 11 Microlex e.U, 8 Gangwal Healthcare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 Gangwal Chemicals, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 7 Seppic, 6 Lonza Capsugel, 5 SPI Pharma, 5 DFE Pharma, 5 Ideal Cures Pvt Ltd, 4 Boai NKY Pharmaceuticals Ltd, 4 ACG Worldwide, 3 Prachin Chemical, 3 Vasa Pharmachem, 3 Actylis, 3 Ingredion Pharma Solutions, 3 Kima Chemical, 2 The Dow Chemical Company, 2 Seqens, 2 Ulanqab Kema New Material, 2 Nomisma Healthcare, 2 Qualicaps, 2 Pharmatrans-Sanaq, 1 Aeon Procare, 1 DKSH, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Nanjing Well Pharmaceutical, 1 Finar, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Jai Radhe Sales, 1 Doshion Polyscience

EXCIPIENTS BY APPLICATIONS

61 Fillers, Diluents & Binders, 42 Coating Systems & Additives, 28 Direct Compression, 28 Controlled & Modified Release, 25 Disintegrants & Superdisintegrants, 20 Granulation, 17 Thickeners and Stabilizers, 14 Lubricants & Glidants, 13 Solubilizers, 12 Co-Processed Excipients, 10 Taste Masking, 9 Empty Capsules, 8 Film Formers & Plasticizers, 7 Topical, 6 Chewable & Orodispersible Aids, 5 API Stability Enhancers, 5 Parenteral, 4 Vegetarian Capsules, 3 Emulsifying Agents, 3 Rheology Modifiers, 2 Coloring Agents

GLOBAL SALES INFORMATION

46 US Medicaid Prescriptions, 56 Finished Drug Prices

MARKET PLACE

7 APIs, 5 DOSSIERS // FDF, 1 CONTRACT SERVICES

PATENTS

20 US Patents, 2 US Exclusivities

ANALYTICAL SOLUTION(s)

5 EDQM Standards, 3 USP Standards, 1 JP Standards, 8 Other Ref. Standards

DIGITAL CONTENT

6 Data Compilation & Company Tracker #PharmaFlow, 77 News

Australian Register of Therapeutic Goods list of Approved Drug Products containing 17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one. Original Data : Therapeutic Goods Administration Website

17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

43 Suppliers

28 USDMF

11 CEP/COS

4 JDMF

5 EU WC

19 NDC API

15 Listed Suppliers

DEVELOPMENTS

18 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

4 Suppliers

DOSSIERs // Finished Dosage Forms

288 Dossiers

136 FDA Orange Book

71 Europe

30 Canada

8 Australia

27 South Africa

16 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL-28 - 0.03MG;0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.02MG,0.15MG;0.025MG,0.15MG;0.03MG,0.15MG;0.01MG,N/A

INTRAUTERINE DEVICE;INTRAUTERINE - 52MG

TABLET;ORAL - 0.02MG;0.1MG

INTRAUTERINE DEVICE;INTRAUTERINE - 52MG

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.045MG/24HR;0.015MG/24HR

TABLET;ORAL - 1.5MG

RELATED EXCIPIENT COMPANIES

Suppliers

29 Kerry

17 Roquette

17 BASF

11 Sigachi Industries

11 Corel Pharma Chem

11 Microlex e.U

8 Gangwal Healthcare

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 Gangwal Chemicals

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

7 Seppic

6 Lonza Capsugel

5 SPI Pharma

5 DFE Pharma

5 Ideal Cures Pvt Ltd

4 Boai NKY Pharmaceuticals Ltd

4 ACG Worldwide

3 Prachin Chemical

3 Vasa Pharmachem

3 Actylis

3 Ingredion Pharma Solutions

3 Kima Chemical

2 The Dow Chemical Company

2 Seqens

2 Ulanqab Kema New Material

2 Nomisma Healthcare

2 Qualicaps

2 Pharmatrans-Sanaq

1 Aeon Procare

1 DKSH

1 Qianhao Chemical (Hebei) Co., Ltd

1 Nanjing Well Pharmaceutical

1 Finar

1 Shanghai Welltone Material Technology Co., Ltd

1 Jai Radhe Sales

1 Doshion Polyscience

EXCIPIENTS BY APPLICATIONS

61 Fillers, Diluents & Binders

42 Coating Systems & Additives

28 Direct Compression

TABLET;ORAL-28 - 0.03MG;0.3MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons